| Co-Investigator(Kenkyū-buntansha) |
久保 誠 北里大学, 医療衛生学部, 准教授 (40464804)
伊藤 誠 愛知医科大学, 公私立大学の部局等, 客員教授 (90137117)
高木 秀和 愛知医科大学, 医学部, 准教授 (90288522)
山本 雄一 琉球大学, 医学部附属病院, 講師 (00363672)
三森 龍之 熊本大学, 大学院生命科学研究部(保), 教授 (00117384)
|
|---|
| Budget Amount *help |
¥41,860,000 (Direct Cost: ¥32,200,000、Indirect Cost: ¥9,660,000)
Fiscal Year 2021: ¥7,800,000 (Direct Cost: ¥6,000,000、Indirect Cost: ¥1,800,000)
Fiscal Year 2020: ¥8,190,000 (Direct Cost: ¥6,300,000、Indirect Cost: ¥1,890,000)
Fiscal Year 2019: ¥7,800,000 (Direct Cost: ¥6,000,000、Indirect Cost: ¥1,800,000)
Fiscal Year 2018: ¥7,800,000 (Direct Cost: ¥6,000,000、Indirect Cost: ¥1,800,000)
Fiscal Year 2017: ¥10,270,000 (Direct Cost: ¥7,900,000、Indirect Cost: ¥2,370,000)
|
|---|
| Outline of Final Research Achievements |
The objective of this study is to develop new tools for the assessment of infection and pathogenic risk and to conduct an epidemiological survey of the “neglected tropical diseases” leishmaniasis and Chagas disease. Through this study, the geographic distribution of Leishmania species in Peru and Ecuador was determined, and the prevalence of previously unknown Leishmania species were also reported. We also gained many new insights into the vectors and reservoirs of both parasitic diseases. In addition, we were able to establish new diagnostic and survey systems and apply them to local surveys and diagnostics. The results obtained in this study will lead not only to the rapid and accurate diagnosis of leishmaniasis and Chagas disease and the elucidation of the transmission mechanism, but also to the elucidation of the pathogenesis and the development of the treatments.
|
